Related references
Note: Only part of the references are listed.Amyloid precursor protein and endosomal-lysosomal dysfunction in Alzheimer's disease: inseparable partners in a multifactorial disease
Ralph A. Nixon
FASEB JOURNAL (2017)
Effects of Regular and Long-Acting Insulin on Cognition and Alzheimer's Disease Biomarkers: A Pilot Clinical Trial
Suzanne Craft et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Drugs in Clinical Trials for Alzheimer's Disease: The Major Trends
Sergey O. Bachurin et al.
MEDICINAL RESEARCH REVIEWS (2017)
Structural variation in amyloid-β fibrils from Alzheimer's disease clinical subtypes
Wei Qiang et al.
NATURE (2017)
Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease
Rebecca Sims et al.
NATURE GENETICS (2017)
Multitarget compounds bearing tacrine- and donepezil-like structural and functional motifs for the potential treatment of Alzheimer's disease
Lhassane Ismaili et al.
PROGRESS IN NEUROBIOLOGY (2017)
Revolution of Resting-State Functional Neuroimaging Genetics in Alzheimer's Disease
Patrizia A. Chiesa et al.
TRENDS IN NEUROSCIENCES (2017)
APOE-related risk of mild cognitive impairment and dementia for prevention trials: An analysis of four cohorts
Jing Qian et al.
PLOS MEDICINE (2017)
Design, synthesis, and evaluation of multitarget-directed ligands against Alzheimer's disease based on the fusion of donepezil and curcumin
Jun Yan et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2017)
A Precision Medicine Initiative for Alzheimer's disease: the road ahead to biomarker-guided integrative disease modeling
H. Hampel et al.
CLIMACTERIC (2017)
Targeting Insulin Signaling for the Treatment of Alzheimer's Disease
Yanxing Chen et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2016)
Novel Tacrine-Benzofuran Hybrids as Potent Multitarget-Directed Ligands for the Treatment of Alzheimer's Disease: Design, Synthesis, Biological Evaluation, and X-ray Crystallography
Xiaoming Zha et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Tau and neurodegenerative disease: the story so far
Khalid Iqbal et al.
NATURE REVIEWS NEUROLOGY (2016)
O-GlcNAcylation: A regulator of tau pathology and neurodegeneration
Cheng-Xin Gong et al.
ALZHEIMERS & DEMENTIA (2016)
A review of clinical trial designs used to detect a disease-modifying effect of drug therapy in Alzheimer's disease and Parkinson's disease
David J. M. McGhee et al.
BMC NEUROLOGY (2016)
Alzheimer's disease: the amyloid hypothesis on trial
Judith R. Harrison et al.
BRITISH JOURNAL OF PSYCHIATRY (2016)
The amyloid hypothesis of Alzheimer's disease at 25years
Dennis J. Selkoe et al.
EMBO MOLECULAR MEDICINE (2016)
Design, synthesis, and pharmacological evaluation of multitarget-directed ligands with both serotonergic subtype 4 receptor (5-HT4R) partial agonist and 5-HT6R antagonist activities, as potential treatment of Alzheimer's disease
Samir Yahiaoui et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
In Alzheimer's Disease, 6-Month Treatment with GLP-1 Analog Prevents Decline of Brain Glucose Metabolism: Randomized, Placebo-Controlled, Double-Blind Clinical Trial
Michael Gejl et al.
FRONTIERS IN AGING NEUROSCIENCE (2016)
Multi-Target Directed Donepezil-Like Ligands for Alzheimer's Disease
Mercedes Unzeta et al.
FRONTIERS IN NEUROSCIENCE (2016)
Key Targets for Multi-Target Ligands Designed to Combat Neurodegeneration
Rona R. Ramsay et al.
FRONTIERS IN NEUROSCIENCE (2016)
Novel Multitarget-Directed Ligands (MTDLs) with Acetylcholinesterase (AChE) Inhibitory and Serotonergic Subtype 4 Receptor (5-HT4R) Agonist Activities As Potential Agents against Alzheimer's Disease: The Design of Donecopride
Christophe Rochais et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Design, Synthesis, and Evaluation of Orally Available Clioquinol-Moracin M Hybrids as Multitarget-Directed Ligands for Cognitive Improvement in a Rat Model of Neurodegeneration in Alzheimer's Disease
Zhiren Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Prevention of sporadic Alzheimer's disease: lessons learned from clinical trials and future directions
Sandrine Andrieu et al.
LANCET NEUROLOGY (2015)
Innate Immunity Fights Alzheimer's Disease
Marie-Victoire Guillot-Sestier et al.
TRENDS IN NEUROSCIENCES (2015)
Insulin sensitizers improve learning and attenuate tau hyperphosphorylation and neuroinflammation in 3xTg-AD mice
Yang Yu et al.
JOURNAL OF NEURAL TRANSMISSION (2015)
Long-Acting Intranasal Insulin Detemir Improves Cognition for Adults with Mild Cognitive Impairment or Early-Stage Alzheimer's Disease Dementia (vol 44, pg 897, 2015)
Amy Claxton et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
Alzheimer disease therapeutics: Focus on the disease and not just plaques and tangles
Khalid Iqbal et al.
BIOCHEMICAL PHARMACOLOGY (2014)
Recent Development of Multifunctional Agents as Potential Drug Candidates for the Treatment of Alzheimer’s Disease
Natalia Guzior et al.
CURRENT MEDICINAL CHEMISTRY (2014)
Dietary Polyphenols for Treatment of Alzheimer's Disease- Future Research and Development
D. Sheeja Malar et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2014)
Intranasal insulin restores insulin signaling, increases synaptic proteins, and reduces Aβ level and microglia activation in the brains of 3xTg-AD mice
Yanxing Chen et al.
EXPERIMENTAL NEUROLOGY (2014)
Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases
Christian Hoelscher
JOURNAL OF ENDOCRINOLOGY (2014)
8-Hydroxyquinoline Schiff-base compounds as antioxidants and modulators of copper-mediated Aβ peptide aggregation
Luiza M. F. Gomes et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2014)
Rapid learning for precision oncology
Jeff Shrager et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease
Paula L. McClean et al.
NEUROPHARMACOLOGY (2014)
From the Multifactorial Nature of Alzheimer's Disease to Multitarget Therapy: The Contribution of the Translational Approach
Laura Calza et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2013)
Dual Inhibitors of beta-Amyloid Aggregation and Acetylcholinesterase as Multi-Target Anti-Alzheimer Drug Candidates
Elisabet Viayna et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2013)
Subcutaneous Administration of Liraglutide Ameliorates Alzheimer-Associated Tau Hyperphosphorylation in Rats with Type 2 Diabetes
Yan Yang et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Alzheimer disease therapy-moving from amyloid-β to tau
Ezio Giacobini et al.
NATURE REVIEWS NEUROLOGY (2013)
Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease
Rafael Leon et al.
MEDICINAL RESEARCH REVIEWS (2013)
Pharmacological Characterization of Memoquin, a Multi-Target Compound for the Treatment of Alzheimer's Disease
Valeria Capurro et al.
PLOS ONE (2013)
Multi Target Neuroprotective and Neurorestorative Anti-Parkinson and Anti-Alzheimer Drugs Ladostigil and M30 Derived from Rasagiline
Moussa B.H. Youdim
Experimental Neurobiology (2013)
Drug Repositioning: An Opportunity to Develop Novel Treatments for Alzheimer's Disease
Anne Corbett et al.
PHARMACEUTICALS (2013)
Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive Impairment A Pilot Clinical Trial
Suzanne Craft et al.
ARCHIVES OF NEUROLOGY (2012)
Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis
Kerry Hunter et al.
BMC NEUROSCIENCE (2012)
Ladostigil: A Novel Multimodal Neuroprotective Drug with Cholinesterase and Brain-Selective Monoamine Oxidase Inhibitory Activities for Alzheimer's Disease Treatment
Orly Weinreb et al.
CURRENT DRUG TARGETS (2012)
Val(8)GLP-1 rescues synaptic plasticity and reduces dense core plaques in APP/PS1 mice
Simon Gengler et al.
NEUROBIOLOGY OF AGING (2012)
Cholinergic and neuroprotective drugs for the treatment of Alzheimer and neuronal vascular diseases. II. Synthesis, biological assessment, and molecular modelling of new tacrine analogues from highly substituted 2-aminopyridine-3-carbonitriles
Abdelouahid Samadi et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Benzenediol-berberine hybrids: Multifunctional agents for Alzheimer's disease
Huailei Jiang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Synthesis, biological assessment and molecular modeling of new dihydroquinoline-3-carboxamides and dihydroquinoline-3-carbohydrazide derivatives as cholinesterase inhibitors, and Ca channel antagonists
Isabelle Tomassoli et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Synthesis, biological evaluation of 9-N-substituted berberine derivatives as multi-functional agents of antioxidant, inhibitors of acetylcholinesterase, butyrylcholinesterase and amyloid-β aggregation
Wen-Jun Shan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
The Diabetes Drug Liraglutide Prevents Degenerative Processes in a Mouse Model of Alzheimer's Disease
Paula L. McClean et al.
JOURNAL OF NEUROSCIENCE (2011)
Deficient brain insulin signalling pathway in Alzheimer's disease and diabetes
Ying Liu et al.
JOURNAL OF PATHOLOGY (2011)
Alzheimer's disease neurofibrillary degeneration: pivotal and multifactorial
Khalid Iqbal et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2010)
Mitochondrial dysfunction is a trigger of Alzheimer's disease pathophysiology
Paula I. Moreira et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2010)
Dual-target-directed 1,3-diphenylurea derivatives: BACE 1 inhibitor and metal chelator against Alzheimer's disease
Wenhai Huang et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Development of an Efficient Therapeutic Agent for Alzheimer's Disease: Design and Synthesis of Dual Inhibitors of Acetylcholinesterase and Serotonin Transporter
Narihiro Toda et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2010)
Dual-Acting Drugs: an in vitro Study of Nonimidazole Histamine H3 Receptor Antagonists Combining Anticholinesterase Activity
Matteo Incerti et al.
CHEMMEDCHEM (2010)
Tacrine Derivatives and Alzheimer's Disease
V. Tumiatti et al.
CURRENT MEDICINAL CHEMISTRY (2010)
The Alzheimer's Disease Mitochondrial Cascade Hypothesis
Russell H. Swerdlow et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Design, Synthesis, Biological Properties, and Molecular Modeling Investigations of Novel Tacrine Derivatives with a Combination of Acetylcholinesterase Inhibition and Cannabinoid CB1 Receptor Antagonism
Jos H. M. Lange et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Design, Synthesis, and Biological Evaluation of a Novel Class of γ-Secretase Modulators with PPARγ Activity
Martina Hieke et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Novel Tacrine-8-Hydroxyquinoline Hybrids as Multifunctional Agents for the Treatment of Alzheimer's Disease, with Neuroprotective, Cholinergic, Antioxidant, and Copper-Complexing Properties
Maria Isabel Fernandez-Bachiller et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Bivalent β-Carbolines as Potential Multitarget Anti-Alzheimer Agents
Yvonne Rook et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Dysregulation of Insulin Signaling, Glucose Transporters, O-GlcNAcylation, and Phosphorylation of Tau and Neurofilaments in the Brain Implication for Alzheimer's Disease
Yanqiu Deng et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Design, synthesis and biological evaluation of novel dual inhibitors of acetylcholinesterase and β-secretase
Yiping Zhu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Insulin resistance and Alzheimer's disease
Suzanne M. de la Monte
BMB REPORTS (2009)
Tacrine-Melatonin Hybrids as Multifunctional Agents for Alzheimer's Disease, with Cholinergic, Antioxidant, and Neuroprotective Properties
Maria Isabel Fernandez-Bachiller et al.
CHEMMEDCHEM (2009)
Site-Activated Multifunctional Chelator with Acetylcholinesterase and Neuroprotective-Neurorestorative Moieties for Alzheimer's Therapy
Hailin Zheng et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Novel Anti-Alzheimer's Dimer Bis(7)-Cognitin: Cellular and Molecular Mechanisms of Neuroprotection Through Multiple Targets
Wenming Li et al.
NEUROTHERAPEUTICS (2009)
New tacrine-dihydropyridine hybrids that inhibit acetylcholinesterase, calcium entry, and exhibit neuroprotection properties
Rafael Leon et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Multi-target-directed coumarin derivatives: hAChE and BACE1 inhibitors as potential anti-Alzheimer compounds
Lorna Piazzi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Clinical Trial Design Issues in Mild to Moderate Alzheimer Disease
David S. Knopman
COGNITIVE AND BEHAVIORAL NEUROLOGY (2008)
Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-β in memory-impaired older adults
Mark A. Reger et al.
JOURNAL OF ALZHEIMERS DISEASE (2008)
Multi-target-directed drug design strategy: From a dual binding site acetylcholinesterase inhibitor to a trifunctional compound against Alzheimer's disease
Maria Laura Bolognesi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Subgroups of Alzheimer's disease based on cerebrospinal fluid molecular markers
K Iqbal et al.
ANNALS OF NEUROLOGY (2005)
Neuropharmacolomcal, neuroprotective and amyloid precursor processing properties of selective MAO-B inhibitor antiparkinsonian drug, rasagiline
MBH Youdim et al.
DRUGS OF TODAY (2005)
Further studies on the interaction of the 5-hydroxytryptamine3 (5-HT3) receptor with arylpiperazine ligands.: Development of a new 5-HT3 receptor ligand showing potent acetylcholinesterase inhibitory properties
A Cappelli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease - is this type 3 diabetes?
E Steen et al.
JOURNAL OF ALZHEIMERS DISEASE (2005)
Metabolic/signal transduction hypothesis of Alzheime's disease and other tauopathies
K Iqbal et al.
ACTA NEUROPATHOLOGICA (2005)
Alzheimer's disease: the two-hit hypothesis
XW Zhu et al.
LANCET NEUROLOGY (2004)
The importance of propargylamine moiety in the anti-Parkinson drug rasagiline and its derivatives for MAPK-dependent amyloid precursor protein processing
M Yogev-Falach et al.
FASEB JOURNAL (2003)
Brain glucose and energy metabolism abnormalities in sporadic Alzheimer disease. Causes and consequences: an update
S Hoyer
EXPERIMENTAL GERONTOLOGY (2000)
Share Paper
